Пређи на садржај

Faktor VIII

С Википедије, слободне енциклопедије
Koagulacioni faktor VIII, prokoagulantna komponenta
PDB prikaz paziran na 2R7E​.
Dostupne strukture
1CFG​, 1D7P​, 1IQD​, 2R7E​, 3CDZ​, 3HNB​, 3HNY​, 3HOB​, 3J2Q​, 3J2S​, 4BDV
Identifikatori
Simboli F8; AHF; DXS1253E; F8B; F8C; FVIII; HEMA
Vanjski ID OMIM300841 MGI88383 HomoloGene49153 GeneCards: F8 Gene
Pregled RNK izražavanja
podaci
Ortolozi
Vrsta Čovek Miš
Entrez 2157 14069
Ensembl ENSG00000185010 ENSMUSG00000031196
UniProt P00451 Q06194
RefSeq (mRNA) NM_000132 NM_001161373
RefSeq (protein) NP_000123 NP_001154845
Lokacija (UCSC) Chr HG1497_PATCH:
154.04 - 154.23 Mb
Chr X:
75.17 - 75.38 Mb
PubMed pretraga [1] [2]

Faktor VIII (FVIII) je esencijalni protein zgrušavanja krvi. On je takođe poznat kao antihemofilički faktor (AHF). Kod ljudi, faktor VIII je Kodiran F8 genom.[1][2] Defekti tog gena dovode do hemophilije A, recesivnog X-vezanog koagulacionog poremećaja.[3]

  1. ^ Toole JJ, Knopf JL, Wozney JM, Sultzman LA, Buecker JL, Pittman DD, Kaufman RJ, Brown E, Shoemaker C, Orr EC (1984). „Molecular cloning of a cDNA encoding human antihaemophilic factor”. Nature. 312 (5992): 342—7. PMID 6438528. doi:10.1038/312342a0. 
  2. ^ Truett MA, Blacher R, Burke RL, Caput D, Chu C, Dina D, Hartog K, Kuo CH, Masiarz FR, Merryweather JP (1985). „Characterization of the polypeptide composition of human factor VIII:C and the nucleotide sequence and expression of the human kidney cDNA”. DNA. 4 (5): 333—49. PMID 3935400. doi:10.1089/dna.1985.4.333. 
  3. ^ Antonarakis SE (1995). „Molecular genetics of coagulation factor VIII gene and hemophilia A”. Thromb. Haemost. 74 (1): 322—8. PMID 8578479. 
  • Gitschier J (1991). „The molecular basis of hemophilia A”. Ann. N. Y. Acad. Sci. 614 (1 Process in Va): 89—96. PMID 1902642. doi:10.1111/j.1749-6632.1991.tb43694.x. 
  • White GC, Shoemaker CB (1989). „Factor VIII gene and hemophilia A”. Blood. 73 (1): 1—12. PMID 2491949. 
  • Antonarakis SE, Kazazian HH, Tuddenham EG (1995). „Molecular etiology of factor VIII deficiency in hemophilia A”. Hum. Mutat. 5 (1): 1—22. PMID 7728145. doi:10.1002/humu.1380050102. 
  • Lenting PJ, van Mourik JA, Mertens K (1999). „The life cycle of coagulation factor VIII in view of its structure and function”. Blood. 92 (11): 3983—96. PMID 9834200. 
  • Saenko EL; Ananyeva N; Kouiavskaia D; et al. (2003). „Molecular defects in coagulation Factor VIII and their impact on Factor VIII function”. Vox Sang. 83 (2): 89—96. PMID 12201837. doi:10.1046/j.1423-0410.2002.00183.x. 
  • Lollar P (2003). „Molecular characterization of the immune response to factor VIII”. Vox Sang. 83. Suppl 1: 403—8. PMID 12617176. 
  • Fay PJ (2004). „Activation of factor VIII and mechanisms of cofactor action”. Blood Rev. 18 (1): 1—15. PMID 14684146. doi:10.1016/S0268-960X(03)00025-0. 
  • Lavigne-Lissalde G, Schved JF, Granier C, Villard S (2005). „Anti-factor VIII antibodies: a 2005 update”. Thromb. Haemost. 94 (4): 760—9. PMID 16270627. doi:10.1160/TH05-02-0118. 
  • Fang H, Wang L, Wang H (2007). „The protein structure and effect of factor VIII”. Thromb. Res. 119 (1): 1—13. PMID 16487577. doi:10.1016/j.thromres.2005.12.015. 

Spoljašnje veze

[уреди | уреди извор]